Interactions between various microbes and ginseng botanicals

Critical Reviews in Microbiology

Volumn 37, Issue 2, 2011, Pages 113-120

  Tournas, V H ^a   Kohn, J S ^a   Katsoudas, E J ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

bacterial fungal spoilage; Ginseng botanicals; ginsenoside biotransformation; microbial inhibition

Indexed keywords

GINSENOSIDE;

ACREMONIUM; ALTERNARIA; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIVIRAL ACTIVITY; ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; BACTERIUM CONTAMINATION; BACTEROIDES; BIFIDOBACTERIUM; CANDIDA ALBICANS; CAULOBACTER; EUROTIUM; FUNGAL CONTAMINATION; FUSARIUM; FUSARIUM OXYSPORUM; FUSOBACTERIUM; GINSENG; MICROORGANISM; PAECILOMYCES; PENICILLIUM; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PSEUDOMONAS AERUGINOSA; REVIEW; RHIZOPUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; FOOD MICROBIOLOGY; FUNGI; GINSENOSIDES; HUMANS; PANAX; PLANT EXTRACTS;

ACREMONIUM STRICTUM; ALTERNARIA; ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; BACTERIA (MICROORGANISMS); BACTEROIDES SP.; BIFIDOBACTERIUM SP.; CANDIDA ALBICANS; CAULOBACTER LEIDYIA; EUROTIUM; FUNGI; FUSARIUM OXYSPORUM; FUSARIUM SACCHARI; FUSOBACTERIUM SP.; INTRASPORANGIUM; MICROBACTERIUM SP.; MYROTHECIUM VERRUCARIA; PANAX GINSENG; PENICILLIUM; PORPHYROMONAS GINGIVALIS; PROPIONIBACTERIUM ACNES; PSEUDOMONAS AERUGINOSA; RHIZOPUS STOLONIFER; STAPHYLOCOCCUS AUREUS;

EID: 79953893980     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2010.520670     Document Type: Review

References (65)

1. Bae EA, Han, MJ, Baek NI, Kim DH.(2001). In vitro anti-Helicobacter pylori activity of panaxytriol isolated from ginseng. Arch Pharmacol Res, 24, 297-9. (Pubitemid 33703576)
2. Bae EA, Han MJ, Choo MK, Park S, Kim DH. (2002). Metabolism of 20(S)-and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol Pharm Bull, 25, 58-63.
3. Bae EA, Park SY, Kim DH. (2000). Constitutive β-glucosidases hydrolyzing ginsenosides Rb1 and Rb2 from human intestinal bacteria. Biol Pharm Bull, 23, 1481-5.
4. Bae EA, Shin E, Kim DH. (2005). Metabolism of ginsenoside Re by human intestinal microfora and its estrogenic efect. Biol Pharm Bull, 28, 1903-8.
5. Belogortseva NL, Yoon JY, Kim KH. (2000). Inhibition of Helicobacter pylori hemagglutination by polysaccharide fraction from roots of Panax ginseng. Planta Med, 66, 217-20. (Pubitemid 30235580)
6. Bi W, Yang JX, Gao WW. (2008). Efect of organic amendments on soil fungi community and continuous cropping Panax quinquefolius. Zhong Yao Cai, 31, 951-4.
7. Calvo AM, Bok JW, Brooks W, Keller NP. (2004). veA is required for toxin and sclerotial production in Aspergillus parasiticus. Appl Environ Microbiol, 70, 4733-9. (Pubitemid 39095499)
8. Calvo AM, Wilson RA, Bok JW, Keller NP. (2002). Relationship between secondary metabolism and fungal development. Microbiol Mol Biol Rev, 66, 447-59. (Pubitemid 35001139)
9. Chen G, Yang M, Song Y, Lu Z, Zhang J, Huang H, Guan S, Wu L, Guo D. (2008). Comparative analysis on microbial and rat metabolism of ginsenoside Rb1 by high-performance liquid chromatography coupled with tandem mass spectrometry. Biomed Chromatography, 22, 779-85.
10. Cheng LQ, Kim MK, Lee JW, Lee YJ, Yang DC. (2006). Conversion of major ginsenoside Rb1 to ginsenoside F2 by Caulobacter leidyia. Biotechnol Lett, 28, 1121-7.
11. Cheng LQ, Na JR, Bang MH, Kim MK, Yang DC. (2008). Conversion of major ginsenoside Rb1 to 20(S)-ginsenoside Rg3 by Microbacterium sp. GS514. Phytochemistry, 69, 218-24. (Pubitemid 350256793)
12. Cheng LQ, Na JR, Kim MK, Bang MH. (2007). Microbial conversion of ginsenoside Rb1 to minor ginsenoside F2 and gypenoside XVII by Intrasporangium sp. GS603 isolated from soil. J Microbiol Biotechnol, 17, 1937-43.
13. Chi H, Kim DH, Ji GE. (2005). Transformation of ginsenosides Rb2 and Rc from Panax ginseng by food microorganisms. Biol Pharm Bull, 28, 2102-05. (Pubitemid 41634259)
14. Cho KM, Hong SY, Lee SM, Kim YH, Kahng GG, Lim P, Kim H, Yun HD. (2007). Endophytic bacterial communities in ginseng and their antifungal activity against pathogens. Microbiol Ecol, 54, 341-51. (Pubitemid 47197908)
15. Choi KT. (2008). Botanical characteristics, pharmacological efects and medicinal components of Korean Panax ginseng CA Meyer. Acta Pharmacol Sin, 29, 1109-18.
16. Christensen LP. (2008). Ginsenosides: Chemistry, biosynthesis, analysis and potential health efects. Adv Food Nutr Res, 55, 1-99.
17. D'Angelo L, Grimaldi R, Caravaggi M, Marcoli M, Perucca E, Lecchini S, Frigo GM, Crema A. (1986). A double-blind, placebo-controlled clinical study on the efect of a standardized ginseng extract on psychomotor performance in healthy volunteers. J Ethnopharmacol, 16, 15-22. (Pubitemid 16091747)
18. 1 by Rhizopus stolonifer and Curvularia lunata. Biotechnol Lett, 25, 339-44. (Pubitemid 36325787)
19. Davydov M, Krikorian AD. (2000). Eleutherococcus senticosus (Rpr. and Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look. J Ethnopharmacol, 72, 345-93.
20. D'Ovidio K, Trucksess M, Weaver C, Horn E, McIntosh M, Bean G. (2006). Afatoxins in ginseng roots. Food Addit Contam, 23, 174-80.
21. Glatthaar-Saalmuller B, Sacher F, Esperester A. (2001). Antiviral activity of an extract derived from roots of Eleutherococcus senticosus. Antiv Res, 50, 223-8. (Pubitemid 32523013)
22. Gray SL, Lackey BR, Tate PL, Riley MB, Camper ND. (2004). Mycotoxins in root extracts of American and Asian ginseng bind estrogen receptors α and β. Exp Biol Med, 229, 560-8. (Pubitemid 38736326)
23. Gross D, Shenkman Z, Bleiberg B, Dayan M, Gittelson M, Efrat R. (2002). Ginseng improves the pulmonary functions and exercise capacity in patients with COPD. Monaldi Arch Chest Dis, 57, 242-6. (Pubitemid 36637236)
24. Han SU, Kim YB, Joo HJ, Hahm KB, Lee WH, Cho Y, Kim DY, Kim MW. (2002). Helicobacter pylori infection promotes gastric carcinogenesis in a mice model. J Gastroenterol Hepatol, 17, 253-61. (Pubitemid 34534096)
25. Hasegawa H, Matsumiya S, Uchiyama M, Kurokawa T, Inouye Y, Kasai R, Ishibashi S, Yamasaki K. (1994). Inhibitory efect of some triterpenoid saponins on glucose transport in tumor cells and its application to in vitro cytotoxic and antiviral activities. Planta Med, 60, 240-3. (Pubitemid 24207717)
26. Hasegawa H, Sung JH, Benno Y. (1997a). Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta Med, 63, 436-40. (Pubitemid 27399983)
27. Hasegawa H, Sung JH, Huh JD. (1997b). Ginseng intestinal bacterial metabolite IH901 as a new antimetastatic agent. Arch Pharm Res, 20, 539-44. (Pubitemid 127697216)
28. Helms S. (2004). Cancer prevention and therapeutics: Panax ginseng. Alt Med Rev, 9, 259-74. (Pubitemid 39299200)
29. Kim CY, Im HW, Kim HK, Hur H. (2001). Accumulation of 2,5-dimethoxy-1,4-benzoquinone in suspension cultures of Panax ginseng by a fungal elicitor preparation and a yeast elicitor preparation. Appl Microbiol Biotechnol, 56, 239-42. (Pubitemid 32661563)
30. Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, Im DS. (2004). Efects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res, 27, 429-35.
31. Kim SH, Park KS. (2003). Efects of Panax ginseng extract on lipid metabolism in humans. Pharmacol Res, 48, 511-3.
32. Lam SK, Ng TB. (2002a). Pananotin a potential antifungal protein from roots of the traditional Chinese medicinal herb Panax notoginseng. Planta Med, 68, 1024-8. (Pubitemid 35448999)
33. Lam SK, Ng TB. (2002b). A xylanase from roots of sanchi ginseng (Panax notoginseng) with inhibitory efects on human immunodefciency virus-1 reverse transcriptase. Life Sci, 70, 3049-58. (Pubitemid 34442702)
34. Lee BH, Lee SJ, Hurl JH, Lee S, Sung JH, Huh JD and Moon CK. (1998). In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria. Planta Med, 64, 500-3. (Pubitemid 28383879)
35. Lee JH, Lee JS. (2004). In vitro anti-adhesive activity of an acidic polysaccharide from Panax ginseng on Porphyromonas gingivalis binding to erythrocytes. Planta Med, 70, 566-8.
36. Lee JH, Park EK, Uhm CS, Chung MS, Kim KH. (2004). Inhibition of Helicobacter pylori adhesion to human gastric adenocarcinoma epithelial cells by acidic polysaccharides from Artemisia capillaris and Panax ginseng. Planta Med, 70, 615-9.
37. Lee JH, Shim JS, Chung MS, Lim ST, Kim KH. (2009). Inhibition of pathogen adhesion to host cells by polysaccharides from Panax ginseng. Biosci Biotechnol Biochem, 73, 209-12.
38. Lee JH, Shim JS, Lee JS, Kim H, Chung MS, Kim KH. (2006). Pectinlike acidic polysaccharide from Panax ginseng with selective anti-adhesive activity against pathogenic bacteria. Carbohydr Res, 341, 1154-63.
39. Lee SJ, Ko WG, Kim JH, Sung JH, Lee SJ, Moon CK, Lee BH. (2000). Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease. Biochem Pharmacol, 60, 677-85.
40. Lee SY, Shin YW, Hahm KB. (2008). Phytoceuticals: Mighty but ignored weapons against Helicobacter pylori infection. J Dig Dis, 9, 129-39.
41. Liu CX, Xiao PG.(1992). Recent advances on ginseng research in China. J Ethnopharmacol, 36, 27-38.
42. Mazzanti G, Battinelli L, Daniele C, Constantini S, Ciaralli L, Evandri MG. (2008). Purity control of some Chinese crude herbal drugs marketed in Italy. Food Chem Toxicol, 46, 3043-7.
43. Ng TB. (2006). Pharmacological activity of Sanchi ginseng (Panax notoginseng). J Pharm Pharmacol, 58, 1007-19. (Pubitemid 44213633)
44. Nicol RW, Traquair JA, Bernards MA. (2002). Ginsenosides as host resistance factors in American ginseng (Panax quinquefolius). Can J Bot, 80, 557-62. (Pubitemid 34744279)
45. Nicol RW, Yousef L, Traquair JA, Bernards MA. (2003). Ginsenosides stimulate the growth of soilborne pathogens of American ginseng. Phytochemistry, 64, 257-64. (Pubitemid 37101811)
46. Park S, Yeo M, Jin JH, Lee KM, Jung JY, Choue R, Cho SW, Hahm KB. (2005). Rescue of Helicobacter pylori-induced cytotoxicity by red ginseng. Dig Dis Sci, 50, 1218-27. (Pubitemid 41184746)
47. Raman P, Patino LC, Nair NG. (2004). Evaluation of metal and microbial contamination in botanical supplements. J Agric Food Chem, 52, 7822-7. (Pubitemid 40063590)
48. Reeleder RD. (2007). Rhexocercosporidium panacis sp. nov., a new anamorphic species causing rusted root of ginseng (Panax quinquefolius). Mycologia, 99, 91-8. (Pubitemid 46953977)
49. Reeleder RD, Hoke SM, Zhang Y. (2006). Rusted root of ginseng (Panax quinquefolius) is caused by a species of Rhexocercosporidium. Phytopathology, 96, 1243-54. (Pubitemid 44631050)
50. Scaglione F, Cogo R, Cocuzza C, Arcidiacono M, Beretta A. (1994). Immunomodulatory efects of Panax ginseng C. A. Meyer (G115) on alveolar macrophages from patients sufering with chronic bronchitis. Int J Immunother, 10, 21-4. (Pubitemid 24124442)
51. Seifert KA., McMullen CR, Yee D, Reeleder RD, Dobinson K F. (2003). Molecular diferentiation and detection of ginseng-adapted isolates of the root rot fungus Cylindrocarpon destructans. Phytopathology, 93, 1533-42. (Pubitemid 37481669)
52. Song Z, Johansen HK, Faber V, Moser C, Kharazmi A, Rygaard J, Hoiby N. (1997). Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats. Antimicrob Agents Chemother, 41, 961-4. (Pubitemid 27194168)
53. Sung WS, Lee DG. (2008). In vitro candidacidal action of Korean red ginseng saponins against Candida albicans. Biol Pharm Bull, 31, 139-42.
54. Tournas VH, Katsoudas E, Miracco EJ. (2006). Moulds, yeasts and aerobic plate counts in ginseng supplements. Int J Food Microbiol, 108, 178-81.
55. Trucksess MW, Weaver CM, Oles CJ, Rump LV, White KD, Betz JM, Rader JI. (2007). Use of multitoxin immunoafnity columns for determination of afatoxins and ochratoxin A in ginseng and ginger. J AOAC Int, 90, 1042-9. (Pubitemid 47266058)
56. Woo JS, Ha BH, Kim TG, Lim Y, Kim KH. (2001). Development of an enzyme-linked glycosorbent method to monitor the inhibition of sialic acid-dependent Helicobacter pylori adhesion. Biotechnol Lett, 23, 507-11. (Pubitemid 32299431)
57. Xiuli W, Yan W, Wenqian Z, Yixuan Z. (2008). Fungal biotransformation of ginsenoside Rg3. Wei Sheng Wu Xue Bao, 48, 1181-5.
58. Xu LL, Han T, Wu JZ, Zhang QY, Zhang H, Huang BK, Rahman K, Qin LP.(2009). Comparative research of chemical constituents, antifungal and antitumor properties of Panax ginseng and its endophytic fungus. Phytomedicine, 16, 609-16.
59. Yang G, Yu Y. (1990). Immunopotentiating efect of traditional Chinese drugs -ginsenoside and glychyrrhiza polysaccharide. Proc Chin Acad Med Sci Pek Union Med Coll, 5, 188-93.
60. Yu YH, Ohh SH. (1993). Research on ginseng disease in Korea. Kor J Gins Sci, 17, 61-8.
61. Zhang G, Ding W. (1990). A preliminary report on the phytophthora root rot of Panax ginseng C.A. Meyer. Zhongguo Zhong Yao Za Zhi, 15, 18-9, 62.
62. Zhang J, Guo H, Tian Y, Liu P, Li N, Zhou J, Guo D. (2007). Biotransformation of 20(S)-protopanaxatriol by Mucor spinosus and the cytotoxic structure-activity relationships of the transformed products. Phytochemistry, 68, 2523-30. (Pubitemid 47451448)
63. Zhang GZ, Zhang SF. (2002). Fungal detection of American ginseng seeds from Beijing and northeast area in China. Zhongguo Zhongyao Zazhi, 27, 658-61.
64. Zhang, GZ, Zhang SF. (2004). Pathogenicity of fungi isolated from American ginseng seeds and bioassay of fungicides against the pathogenic fungi. Zhongguo Zhong Yao Za Zhi, 29, 138-41.
65. Zhou W, Yan Q, Li J-Y Zhang, X-C, Zhou P. (2008). Biotransformation of Panax notoginseng saponins into ginsenoside compound K production by Paecilomyces bainier sp. 229. J Appl Microbiol, 104, 699-706. (Pubitemid 351257729)